关于他汀类药物诱发肌病的机制 - Suppr

Suppr

超能文献

On the mechanisms of statin-induced myopathy.

作者信息

Laaksonen Reijo

机构信息

Tampere University Hospital, Tampere, Finland.

出版信息

Clin Pharmacol Ther. 2006 Jun;79(6):529-31. doi: 10.1016/j.clpt.2006.02.013. Epub 2006 May 2.

DOI:10.1016/j.clpt.2006.02.013

PMID:16765140

Abstract

摘要

相似文献

On the mechanisms of statin-induced myopathy.

Clin Pharmacol Ther. 2006 Jun;79(6):529-31. doi: 10.1016/j.clpt.2006.02.013. Epub 2006 May 2.

Statin myopathy: the iceberg or its tip?

Muscle Nerve. 2006 Oct;34(4):387-90. doi: 10.1002/mus.20603.

[Statin-induced muscular problems are underestimated].

Ugeskr Laeger. 2010 Apr 19;172(16):1235; author reply 1235.

Statin induced myopathy.

J Insur Med. 2009;41(2):132-5.

Statin myopathies: pathophysiologic and clinical perspectives.

Clin Invest Med. 2001 Oct;24(5):258-72.

Worsening myopathy associated with ezetimibe in a patient with McArdle disease.

QJM. 2005 Jun;98(6):461-2. doi: 10.1093/qjmed/hci074.

Issues in statin-associated myopathy.

JAMA. 2003 Aug 20;290(7):888; author reply 888-9. doi: 10.1001/jama.290.7.888-b.

The effects of CoQ10 supplements on patients taking statin drugs.

Gen Dent. 2010 May-Jun;58(3):168-70.

Potential adverse effects of statins on muscle.

Phys Ther. 2005 May;85(5):459-65.

Succinylcholine should be avoided in patients on statin therapy.

Anesthesiology. 2011 Jul;115(1):6-7. doi: 10.1097/ALN.0b013e3182207a16.

引用本文的文献

Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.

Am J Pathol. 2014 Aug;184(8):2322-32. doi: 10.1016/j.ajpath.2014.04.013. Epub 2014 Jun 5.

Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review.

Genet Med. 2014 Nov;16(11):810-9. doi: 10.1038/gim.2014.41. Epub 2014 May 8.

Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.

Br J Clin Pharmacol. 2014 Sep;78(3):649-59. doi: 10.1111/bcp.12367.

UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone.

Mol Diagn Ther. 2013 Aug;17(4):233-7. doi: 10.1007/s40291-013-0031-x.

Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Pharmacogenomics. 2012 Apr;13(5):579-94. doi: 10.2217/pgs.12.11.

Statin induced myopathy presenting as mechanical musculoskeletal pain observed in two chiropractic patients.

J Can Chiropr Assoc. 2010 Mar;54(1):43-51.

Myopathy with statin-fibrate combination therapy: clinical considerations.

Nat Rev Endocrinol. 2009 Sep;5(9):507-18. doi: 10.1038/nrendo.2009.151. Epub 2009 Jul 28.

Genetic determinants of statin intolerance.

Lipids Health Dis. 2007 Mar 21;6:7. doi: 10.1186/1476-511X-6-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

On the mechanisms of statin-induced myopathy.

作者信息

Laaksonen Reijo

机构信息

Tampere University Hospital, Tampere, Finland.

出版信息

Clin Pharmacol Ther. 2006 Jun;79(6):529-31. doi: 10.1016/j.clpt.2006.02.013. Epub 2006 May 2.

DOI:10.1016/j.clpt.2006.02.013

PMID:16765140

Abstract

摘要

相似文献

On the mechanisms of statin-induced myopathy.

Clin Pharmacol Ther. 2006 Jun;79(6):529-31. doi: 10.1016/j.clpt.2006.02.013. Epub 2006 May 2.

Statin myopathy: the iceberg or its tip?

Muscle Nerve. 2006 Oct;34(4):387-90. doi: 10.1002/mus.20603.

[Statin-induced muscular problems are underestimated].

Ugeskr Laeger. 2010 Apr 19;172(16):1235; author reply 1235.

Statin induced myopathy.

J Insur Med. 2009;41(2):132-5.

Statin myopathies: pathophysiologic and clinical perspectives.

Clin Invest Med. 2001 Oct;24(5):258-72.

Worsening myopathy associated with ezetimibe in a patient with McArdle disease.

QJM. 2005 Jun;98(6):461-2. doi: 10.1093/qjmed/hci074.

Issues in statin-associated myopathy.

JAMA. 2003 Aug 20;290(7):888; author reply 888-9. doi: 10.1001/jama.290.7.888-b.

The effects of CoQ10 supplements on patients taking statin drugs.

Gen Dent. 2010 May-Jun;58(3):168-70.

Potential adverse effects of statins on muscle.

Phys Ther. 2005 May;85(5):459-65.

Succinylcholine should be avoided in patients on statin therapy.

Anesthesiology. 2011 Jul;115(1):6-7. doi: 10.1097/ALN.0b013e3182207a16.

引用本文的文献

Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.

Am J Pathol. 2014 Aug;184(8):2322-32. doi: 10.1016/j.ajpath.2014.04.013. Epub 2014 Jun 5.

Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review.

Genet Med. 2014 Nov;16(11):810-9. doi: 10.1038/gim.2014.41. Epub 2014 May 8.

Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.

Br J Clin Pharmacol. 2014 Sep;78(3):649-59. doi: 10.1111/bcp.12367.

UGT1A1*28 is associated with decreased systemic exposure of atorvastatin lactone.

Mol Diagn Ther. 2013 Aug;17(4):233-7. doi: 10.1007/s40291-013-0031-x.

Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Pharmacogenomics. 2012 Apr;13(5):579-94. doi: 10.2217/pgs.12.11.

Statin induced myopathy presenting as mechanical musculoskeletal pain observed in two chiropractic patients.

J Can Chiropr Assoc. 2010 Mar;54(1):43-51.

Myopathy with statin-fibrate combination therapy: clinical considerations.

Nat Rev Endocrinol. 2009 Sep;5(9):507-18. doi: 10.1038/nrendo.2009.151. Epub 2009 Jul 28.

Genetic determinants of statin intolerance.

Lipids Health Dis. 2007 Mar 21;6:7. doi: 10.1186/1476-511X-6-7.